Anixa Biosciences, Inc. - ANIX
About Gravity Analytica
Recent News
- 12.15.2025 - Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
- 12.12.2025 - 8-K - Current report
- 12.11.2025 - Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
- 12.10.2025 - Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
- 11.17.2025 - Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
- 11.12.2025 - Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
- 11.10.2025 - Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
- 11.05.2025 - Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
- 10.31.2025 - 4 - Statement of changes in beneficial ownership of securities
- 10.23.2025 - Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference